ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
AVITA Medical Receives U.S. FDA Investigational Device Exemption Approval biospectrumasia
September 18, 2019The pivotal studies leading to the RECELL System’s FDA premarket approval (PMA) for the treatment of acute thermal burns demonstrated that the RECELL System treated burns using 97.5 percent less donor skin when used alone in second-degree burns, and 32 pe -
Avita Medical to commercialize wounds treatment device in Japan biospectrumasia
March 08, 2019Australia based AVITA Medical, regenerative medicine company, announced that it has collaborated with COSMOTEC, an M3 Group company, to market and distribute the RECELL? Autologous Cell Harvesting Device (RECELL? System) for the treatment of burns and oth -
Avita Medical to commercialize wounds treatment device in Japan biospectrumasia
March 06, 2019Australia based AVITA Medical, regenerative medicine company, announced that it has collaborated with COSMOTEC, an M3 Group company, to market and distribute the RECELL? Autologous Cell Harvesting Device (RECELL? System) for the treatment of burns and oth
Pharma Sources Insight January 2025
